The Pharmaceutical Journal·4 min read·medium
Three-quarters of pharmacies expect surge in demand for weight-loss pill
✦AI Summary
UK pharmacies are preparing for a surge in demand for the newly approved oral weight-loss pill, Wegovy. While the drug offers a non-injectable alternative for patients, pharmacists have expressed significant concerns regarding the rise of unregulated black-market sales.
More than three-quarters (76%) of pharmacies expect to start “significant numbers” of eligible patients on oral Wegovy (semaglutide; Novo Nordisk) , a survey by the National Pharmacy Association (NPA) has found.
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in